| Literature DB >> 27662308 |
Yoshihisa Kitamura1,2, Masatoshi Inden3, Yasuto Kimoto2, Kazuyuki Takata2, Daijiro Yanagisawa4, Masanori Hijioka1, Eishi Ashihara2, Ikuo Tooyama4, Shun Shimohama5, Hiroyoshi Ariga6.
Abstract
Previously, DJ-1 modulator UCP0054278/comp-B was identified by virtual screening, where comp-B interacts with DJ-1 to produce antioxidant and neuroprotective responses in Parkinson's disease models. However, the effect of comp-B in an in vivo Alzheimer's disease (AD) model is yet undetermined. Thus, we examined the effect of comp-B on spatial learning, memory, and amyloid-β (Aβ) clearance in a transgenic mouse model of AD. We found that comp-B resolved the cognitive deficits, reduced insoluble Aβ42 levels, and prevented the degeneration of synaptic functions, thereby suggesting that comp-B may become a major compound for AD treatment.Entities:
Keywords: Alzheimer’s disease; DJ-1; Parkinson’s disease; amyloid-β
Mesh:
Substances:
Year: 2017 PMID: 27662308 DOI: 10.3233/JAD-160574
Source DB: PubMed Journal: J Alzheimers Dis ISSN: 1387-2877 Impact factor: 4.472